drugset / Trial / NCT00241904

Reducing Total Cardiovascular Risk in an Urban Community

NCT00241904

RandomizedParallel-groupOpen-labelPrevention

Summary

PLEASE NOTE: THIS STUDY IS ONLY ENROLLING PATIENTS CURRENTLY BEING TREATED AT BELAIR-EDISON FAMILY HEALTH CENTER. The purpose of this study is to compare the clinical effectiveness and cost effectiveness of two cardiovascular risk reduction programs - a comprehensive intensive (Cl) intervention with a less intensive (LI) intervention - in African American, and white low-income patients with known excessive cardiovascular disease risk.

Timeline

Start
2006-05
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 81 mg
Subject Atenolol Other / unclassified Oral
Subject LISINOPRIL ANHYDROUS Small molecule Oral
Subject Metoprolol Other / unclassified Oral
Subject Propranolol Small molecule Oral